Doug Kaden, MBA
Doug Kaden is a board member of Orange Grove Bio (“OGB”), a pre-clinical drug development company. He previously co-founder and built Varagon Capital, a direct lending business, to $8 billion in AUM in 5 years, generating a 34x return for equity investors and several hundred million of alpha for the founding limited partner. Prior to Varagon, he was a senior partner at Oak Hill Capital, a mid-market private equity firm. He was a member of the Executive Committee that ran the firm, the Investment Committee, as well as founding member of the ESG committee. His originated portfolio at Oak Hill generated a 3.1x ROI and 25% IRR. He hopes to use his experiences, alongside Orange Grove Bio CEO, Marc Appel, to further Orange Grove Bios mission to help academics further their goals.
Doug received a B.A. from Harvard University, an MBA from Stanford University and an mPhil from Cambridge University.